A prospective trial of fungal colonization after laser resurfacing of the face: Correlation between culture positivity and symptoms of pruritus

Dermatologic Surgery

Volumn 29, Issue 3, 2003, Pages 255-260

  Alam, Murad ^a   Pantanowitz, Liron ^b   Harton, Anthony M ^b   Arndt, Kenneth A ^b,c,d,e   Dover, Jeffrey S ^b,d,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SkinCare Physicians   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; ERBIUM;

ACNE; ADULT; ARTICLE; AUREOBASIDIUM PULLULANS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FACE SURGERY; FEMALE; FUNGUS CULTURE; FUNGUS GROWTH; FUSARIUM; HUMAN; LASER SURGERY; LIGHT DAMAGE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; SCALE UP; SCAR FORMATION; SKIN; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CANDIDA; FACE; FEMALE; HUMANS; LASER SURGERY; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PRURITUS; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN;

EID: 0037345753     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29060.x     Document Type: Article

References (31)

1. Gaspar Z, Vincuillo C, Elliott T. Antibiotic prophylaxis for full-face laser resurfacing: is it necessary? Arch Dermatol 2000;137:313-5.
2. Manuskiatti W, Fitzpatrick RE, Goldman MP, Krejkci-Papa N. Prophylactic antibiotics in patients undergoing laser resurfacing of the skin. J Am Acad Dermatol 1999;40:77-84.
3. Ross EV, Amesbury EC, Barile A, Proctor-Shipman L, Feldman BD. Incidence of postoperative infection or positive culture after facial laser resurfacing: a pilot study, a case report, and a proposal for a rational approach to antibiotic prophylaxis. J Am Acad Dermatol 1998;39:975-81.
4. Conn H, Nanda VS. Prophylactic fluconazole promotes reepithelialization in full-face carbon dioxide laser skin resurfacing. Lasers Surg Med 2000;26:201-7.
5. 2 laser resurfacing infection rates. Dermatol Surg 2000;26:402-3.
6. Gilbert S, McBurney E. Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: a randomized clinical trial of dosing regimens. Dermatol Surg 2000;26:50-4.
7. 2 laser resurfacing and occlusive dressing use. Dermatol Surg 2000;26:32-6.
8. 2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg 1999;25:857-61.
9. Rendon-Pellerano MI, Lentini J, Eaglstein WE, et al. Laser resurfacing: usual and unusual complications. Dermatol Surg 1999;25:360-7.
10. Johnson PJ, Hollins RR. Delayed reactivation of herpes simplex virus infection after facial laser resurfacing. Plast Reconstr Surg 2000;106:743-4.
11. Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing. Dermatol Surg 1998;24:315-20.
12. 2 facial laser resurfacing: aesthetic results and complications. Plast Reconstr Surg 1999;103:592-601.
13. Wall SH, Ramey SJ, Wall F. Famciclovir as antiviral prophylaxis in laser resurfacing procedures. Plast Reconstr Surg 1999;104:1103-8.
14. Demas PN, Bridenstine JB. Diagnosis and treatment of postoperative complications after skin resurfacing. J Oral Maxillofac Surg 1999;57:837-41.
15. Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, Smith SR. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997;23:527-35.
16. Haas AF, Grekin RC. Antibiotic prophylaxis in dermatologic surgery. J Am Acad Dermatol 1995;32:155-76.
17. Yurt RW, McManus AT, Mason AD, Pruitt BA. Increased susceptibility in infection related to extent of burn injury. Arch Surg 1984;119:183-8.
18. Rosenberg GJ, Apfelberg DB, Chernoff WG, Seckel BR. Treatment of postlaser resurfacing complications. Aesthetic Surg J 1997;17:119-23.
19. Burns A. A personal approach to laser skin resurfacing. Aesthetic Surg J 1996;16:272-80.
20. Bernstein LJ, Kauvar ANB, Grossman MC, Geronemus RG. The short- and long-term side effects of carbon dioxide laser resurfacing. Dermatol Surg 1997;23:519-25.
21. Alster TS, West TB. Resurfacing of atrophic scars with a high-energy, pulsed carbon dioxide laser. Dermatol Surg 1995;22:151-5.
22. Waldorf HA, Kauvar ANB, Geronemus RG. Skin resurfacing of fine to deep rytides using a char-free carbon dioxide laser in 47 patients. Dermatol Surg 1995;21:940-6.
23. Alster TS, Nanni CA. Famciclovir prophylaxis of herpes simplex virus activation after laser skin resurfacing. Dermatol Surg 1999;25:242-6.
24. Nanni CA, Alster TS. Herpes simplex prophylaxis for cutaneous laser resurfacing: a comparison of acyclovir, valacyclovir, and famciclovir. Poster Presentation at the 25th Annual Meeting of the American Society for Dermatologic Surgery, Portland, OR, 1998.
25. 2 resurfacing during a multicenter trial [abstract]. Lasers Med Surg 1996;8(Suppl):34.
26. Newman JP, Koch RJ, Goode RL. Closed dressings after laser skin resurfacing. Arch Otolaryngol Head Neck Surg 1998;124:751-7.
27. Alster TS, Lupton JR. Treatment of complications of laser skin resurfacing. Arch Facial Plast Surg 2000;2:279-84.
28. Sullivan SA, Dailey RA. Complications of laser resurfacing and their management. Ophthal Plast Reconstr Surg 2000;16:417-26.
29. 2 laser resurfacing infection rates. Dermatol Surg 2000;26:403-4.
30. Perkins SW, Sklarew EC. Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area. Plast Reconstr Surg 1996;98:427-33.
31. Larone DH. Medically Important Fungi: A Guide to Identification, 3rd ed. Washington, DC: ASM Press, 1995:63, 68, 143, 201.